Table 2.
Depressed participants: Pharmacological and clinical data
| Participant | Medication and Daily Dosage | Duration of Medication | MDD-related Hospitalizations | Duration of Current Episode (months) | Years Since First Episode | BDI |
|---|---|---|---|---|---|---|
| MDD1 | Venlafaxine (300 mg) | 4 months | 0 | 21 | 29 | 15 |
| MDD2 | none | - | NR | NR | NR | 14 |
| MDD3 | Venlafaxine (450 mg) | 2 years | 1 | 1 | 2 | 24 |
| MDD4 | none | - | 0 | 6 | 25 | 13 |
| MDD5 | Escitalopram; Bupropion (dosage NR) | 1.5 years; 4 years | 0 | 6 | 18 | 45 |
| MDD6 | Venlafaxine (150 mg) | 3 years | 0 | 5 | 20 | 34 |
| MDD7 | Duloxetine (40 mg), Bupropion (300 mg) | 1 year; 1 month | 0 | 36 | NR | 25 |
| MDD8 | none | - | 0 | 8 | 25 | 15 |
| MDD9 | Sertraline (100 mg) | 3 months | 0 | 2 | 2 | 41 |
| MDD10 | none | - | 0 | 10 | 7 | 33 |
| MDD11 | none | - | 0 | 4 | 15 | 39 |
| MDD12 | Venlafaxine (225 mg); Bupropion (300 mg) | 5 months; 5 months | 0 | 14 | 1 | 27 |
| MDD13 | Venlafaxine (150 mg) | 2 years | 0 | 28 | 11 | 33 |
| MDD14 | Venlafaxine (75 mg); Bupropion (100 mg) | 1 year; 1 month | 0 | 16 | 5 | 28 |
Note. NR, not reported.